Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of SPARC on gene expression in HepG2

ABSTRACT: Effect of SPARC on gene expression in HepG2

PROVIDER: PRJNA704276 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Effect of SPARC on gene expression in HepG2

Project description:This project focus on the effect of SPARC on liver cancer metastasis.

2021-10-01 | GSE167314 | GEO

SPARC binding protein in HepG2

Project description:SPARC binding proteins detected by mass spectrometer. Cell lysate were collected from HepG2 cells by non-denaturing lysis buffer. Total cell proteins were immnuoprecipitated by SPARC specific antibody from R&D company. SPARC and binding proteins were loaded on SDS-PAGE gel and ran for 30 minutes. The gel was stained with Coomassie Blue and SPARC-binding proteins in gel were cut and send for mass analysis for the detection of the specific proteins.

2021-03-03 | PXD024475 |

Effect of knockdown of KIAA1429 on gene expression in HepG2 cells

Project description:Effect of knockdown of KIAA1429 on gene expression in HepG2 cells

| PRJNA985622 | ENA

Effect of melatonin on gene expression of Hepatocelluar Carcinoma HepG2 cells

Project description:Effect of melatonin on gene expression of Hepatocelluar Carcinoma HepG2 cells

| PRJNA863494 | ENA

Effect of STAT3 deletion on gene expression in HepG2 cell line

Project description:Effect of STAT3 deletion on gene expression in HepG2 cell line

| PRJNA832212 | ENA

Effect of siRNA depletion of SPRTN gene on gene expression in HepG2 cells

Project description:Effect of siRNA depletion of SPRTN gene on gene expression in HepG2 cells

| PRJNA997332 | ENA

RNA-seq of SPARC-treated human corneal epithelial cells

Project description:We identified that Sparc gene expression is upregulated in corneal epithelial cells in a mouse model of dry eye disease involving lacrimal gland excision. Therefore, in this experiment we assess the effect of SPARC treatment on the transcriptome of human corneal epithelial cells.

2022-12-19 | GSE215149 | GEO

The effect of KIF11 knockdown on gene expression profile in HepG2 cells

Project description:The effect of KIF11 knockdown on gene expression profile in HepG2 cells

| PRJNA998071 | ENA

Triple Negative Breast tumors: SPARC Positive Tumors vs SPARC Negative Tumors

Project description:The aim of this study was evaluate the transcriptome changes in the comparison between triple negative tumors with increased SPARC expression and triple negative tumors with decreased SPARC expression according to Nagai et al., 2011 (Breast Cancer Res Treat (2011) 126:1–14) The results generated could be of particular interest to better define the prognostic impact of SPARC expression in triple negative breast tumors

2018-07-01 | GSE98931 | GEO

SPARC Upregulation Mediates Podocyte Injury in Alport Syndrome Mice

Project description:Alport syndrome (AS) is a hereditary kidney disease with no curative treatment, which characterized by hematuria, proteinuria, and progressive kidney failure. Podocyte injury has been observed in AS, whereases, the mechanism is still unclear. Reported studies showed the expression level of secreted protein acidic and rich in cysteine (SPARC) correlated with podocyte injury in chronic kidney diseases, yet its mechanism still unknown. Especially, its role in AS-related podocyte injury is unclear. Therefore, the kidney of Col4a3-/- AS mice was used to detect SPARC expression, location, and podocyte injury, and mouse podocyte cell line (MPC5) was used to explore the mechanism of SPARC-induced podocyte injury. Besides, SPARC expression in both urine and kidney samples from AS patients were analyzed. The results showed, SPARC upregulated and located in podocytes were detected in Col4a3-/- AS mice, and increased inflammatory cytokines, impaired podocyte structure and function were identified in SPARC-overexpression MPC5, importantly, knockdown adhesion G protein-coupled receptor B1 (ADGRB1) exerted a protective effect. In AS patients, urinary increased level of SPARC was detected, SPARC deposition in glomeruli of kidney sections was identified. Our findings identified SPARC as a key mediator of podocyte injury in AS, with ADGRB1 acting as its downstream effector.

2025-10-04 | GSE309489 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data